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Updates 
WHO has produced an update to the living guideline on drugs for COVID-19 
in the article published by by BMJ. It replaces earlier versions (4 September 
and 20 November 2020) and supersedes the BMJ Rapid Recommendations on 
remdesivir published on 2 July 2020. The previous versions can be found as 
data supplements. New recommendations will be published as updates to this 
guideline. (BMJ 2020;370:m3379 https://www.bmj.com/content/370/bmj.
m3379) Click for updates.
Readers note This is the third version (update 2) of the living guideline (BMJ 
2020;370:m3379). When citing this article, please consider adding the update 
number and date of access for clarity.
Abstract
Clinical question What is the role of drug interventions in the treatment of 
patients with COVID-19?
New recommendation The latest version of this WHO living guidance 
provides strong recommendations against the use of hydroxychloroquine and 
lopinavir-ritonavir in patients with COVID-19 regardless of disease severity. 
These recommendations follow the publication of results from the WHO 
SOLIDARITY trial.
Recommendations This guidance adds to recommendations for corticosteroids 
and remdesivir published in the previous versions, with no changes made in this 
update: (a) a strong recommendation for systemic corticosteroids in patients 
with severe and critical COVID-19, (b) a conditional recommendation against 
systemic corticosteroids in patients with non-severe COVID-19, (c) a conditional 
recommendation against remdesivir in hospitalised patients with COVID-19.
How this guideline was created WHO has partnered with the non-profit 
Magic Evidence Ecosystem Foundation (MAGIC) for methodologic support, to 
develop and disseminate living guidance for COVID-19 drug treatments, based 
on a living systematic review and network analysis. An international standing 
Guideline Development Group (GDG) of content experts, clinicians, patients, 
and methodologists produced recommendations following standards for 
trustworthy guideline development using the GRADE approach. No competing 
interests were identified for any panel member.
Understanding the new recommendation When moving from the to the 
strong recommendations against the use of hydroxychloroquine and lopinavir-
ritonavir in patients with COVID-19, the panel was informed by a living 
systematic review and network meta-analysis of 30 trials with 10 921 participants 
for hydroxychloroquine and seven trials with 7429 participants for lopinavir-
ritonavir. The trials for both drugs included inpatients and outpatients. Moderate 
certainty evidence for both drugs demonstrated no reduction in mortality or need 
for mechanical ventilation. There was also low certainty of evidence for harm 
with both drugs, including diarrhoea and nausea/vomiting. The panel did not 
anticipate important variability when it comes to patient values and preferences. 
In addition, the panel decided that contextual factors such as resources, feasibility, 
acceptability, and equity for countries and health care systems did not alter the 
recommendation.
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Background
In South Sudan health services are sparse making it very difficult for some communities, 
especially in isolated areas, to access care. To mitigate this the Ministry of Health (MOH) 
and partners are implementing Primary Health Care (PHC) services with support from donor 
organizations including the World Bank.
The Provision of Essential Health Services Project (PEHSP) started in July 2019 in Upper Nile 
and Jonglei States.[1] Since then many lives have been saved through a variety of interventions. 
One example is Nyaduoth Jock Chuol. 
Nyaduoth Jock was a 5-year-old girl living in the village of Pare in the Western part of 
Yomding Payam, 20 kilometres from Ulang County, Upper Nile State. Pare village has a 
population of about 1500 and most earn a living mainly by farming and cattle rearing. Pare 
community accesses its health services at Rupboard Primary Health Care Centre (PHCC) 
seven kilometres away. This often made it very difficult for mothers and children to get the 
needed healthcare and especially so in the rainy season when flooding cuts communication 
with Rupboard.
One day Nyaduoth Jock was playing around the kitchen where she climbed on a wall and 
accidently fell into a saucepan containing twenty litres of hot water. She sustained serious 
burns to about 32% of her body affecting especially her abdomen (9%), back (9%), legs 
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Figure 1. Reat Jock Banguot (Health 
Project Officer for Lot 5) on his way 
to Pare to do a home visit to check 
Nyaduoth.
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(4%) and hands (6%), where the skin peeled off. This caused 
extreme alarm to the family who were frightened, confused 
and not knowing what to do. 
However, Nyaduoth’s mother, Madam Nyakoang Tong 
suggested rushing Nyaduoth to Rupboard PHCC in case 
her life could be saved. So, in spite of the long journey, 
the parents took her there where she was admitted and the 
necessary care was started by the health workers and the on-
duty Clinical Officer Yien Thomas Maluth.
During this time her parents, especially her father, were 
worried that their daughter may die or develop long term 
complications such as contractures from the burn injury. 
How Nyaduoth Jock’s burns were treated [2,3]
According to South Sudan Treatment Guidelines for burns 
injury, the following treatments were given:
• Cloxacillin 250 mg orally 4 X per day for 7 days 
• Intravenous Ringer Lactate (RL) 2 ml/kg X 32% 
(BSA) plus maintenance fluid (alternation of 
Ringer Lactate and 5 % glucose) for two days
• Paracetamol 250 mg orally 4 X per day
• Silver Sulfadiazine cream applied to the affected 
body parts 2 X per day
• Wound care with 0.9% Saline.
After staying for ten days in Rupboard PHCC, Nyaduoth 
showed signs of improvement. This made the parents gain 
confidence in the services being implemented under PEHSP. 
After a further four days she had continued to progress well 
and was discharged with scars but no serious complications 
and, in particular, no contractures.  Reat Jock Banguot, 
Health Project Officer, later visited the family at home - see 
Figures 1 and 2.
Nyaduoth’s parents thanked the health workers for saving 
their daughter’s life and the entire community of Pare was 
very appreciative of the implementing partners, the South 
Sudan Agency for Internal Development (SSAID), for the 
lifesaving services that were provided in Rupboard PHCC 
and the other supported health facilities.
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Figure 2. Nyaduoth, her father Jock Chuol, and Reat Jock (Health 
Project Officer for Lot 5) during a visit to her home in Pare (Photo 
was taken with Nyaduoth’s father’s permission).
Provision of Essential Health Service Project (PEHSP) is a World Bank project being 
implemented in Upper Nile and Jonglei States. This project was launched on July 1, 2019 to 
support the Ministry of Health (MOH) especially the County Health Department (CHD) in the 
delivery of essential Primary Health Care services to the affected populations. The funding 
is being managed by UNICEF and implemented by Implementing Partners (IPs) among which 
the South Sudan Agency for Internal Development (SSAID) is one. Geographically the areas 
under the two States are divided into Lots (1 to 10) and in each lot there are two or three 
Consortium partners. SSAID and the other two Consortium partners (Universal Network 
for Knowledge and Empowerment Agency, UNKEA and Malaria Consortium, MC) are Lot 
5 Consortium members supporting two Counties (Ulang and Nasir) in Upper Nile State. 
SSAID and UNKEA are supporting a total of 21 health facilities (7 in Ulang and 14 in Nasir) 
while MC is supporting the delivery of Community Health Services through the Boma Health 
Initiative (BHI) especially in the targeted Bomas in both Ulang and Nasir Counties.
